The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Ribozyme Pharmaceuticals, Inc.

Ribozyme Pharmaceuticals, Inc.
Nasdaq: RZYM
Change
symbol:
     
 PROFILE
Ribozyme Pharmaceuticals knows that too much protein can sometimes be a bad thing. The company is developing human ribozyme therapies for diseases caused by the overproduction of damaging proteins. Ribozymes, a form of RNA, inhibit protein production. The firm and partner Chiron are developing lead product candidate Angiozyme as a potential treatment for solid tumors. The company is also developing treatments for hepatitis B and C, and it is developing Herzyme, which may treat breast and other cancers, through Medizyme Pharmaceuticals, a joint venture with Elan (which owns almost 15% of Ribozyme). Ribozyme owns about 30% of Atugen, which provides drug target discovery and validation services.

 COMPETITION
Agouron Pharmaceuticals, Inc. (dossier)
Isis Pharmaceuticals, Inc. (ISIP)
Ribapharm Inc. (dossier)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 15.50
1-Yr. Sales Growth: 101.3%
Employees: 113
Revenue per employee: $137,168.14

 KEY PEOPLE
• Howard W. Robin
    CEO
• Marvin Tancer
    CFO

 CONTACT INFO
2950 Wilderness Place
Boulder, CO 80301
US
Phone: 303-449-6500
Fax: 303-449-6995
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001